Ensign Group Inc

Ensign Group Inc (ENSG)

$88.47

-0.14

(-0.16%)

Market is closed - opens 7 PM, 02 Jun 2023

Insights on Ensign Group Inc

  • Increasing Revenue

    Revenue is up for the last 9 quarters, 627.25M → 886.84M (in $), with an average increase of 4.2% per quarter

  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, 60.47M → 59.85M (in $), with an average decrease of 1.0% per quarter

  • Vs HCA

    In the last 1 year, HCA Healthcare Inc has given 27.7% return, outperforming this stock by 14.3%

  • Vs HCA

    In the last 3 years, HCA Healthcare Inc has given 142.8% return, outperforming this stock by 37.3%

Performance

  • $87.20
    $89.18
    $88.47
    downward going graph

    1.44%

    Downside

    Day's Volatility :2.22%

    Upside

    0.79%

    downward going graph
  • $70.10
    $102.26
    $88.47
    downward going graph

    20.76%

    Downside

    52 Weeks Volatility :31.45%

    Upside

    13.49%

    downward going graph

Returns

PeriodEnsign Group IncSector (Health Care)Index (Russel 2000)
3 Months
-2.07%
0.7%
-6.8%
6 Months
-6.08%
-8.3%
-6.0%
1 Year
13.4%
-1.9%
-4.6%
3 Years
105.54%
25.3%
25.9%

Highlights

Market Capitalization
4.9B
Book Value
$23.79
Dividend Share
0.225
Dividend Yield
0.26%
Earnings Per Share (EPS)
4.11
PE Ratio
21.42
PEG Ratio
1.31
Wall Street Target Price
111.25
Profit Margin
7.32%
Operating Margin TTM
9.46%
Return On Assets TTM
5.48%
Return On Equity TTM
19.61%
Revenue TTM
3.2B
Revenue Per Share TTM
58.11
Quarterly Revenue Growth YOY
24.3%
Gross Profit TTM
534.9M
EBITDA
366.2M
Diluted Eps TTM
4.11
Quarterly Earnings Growth YOY
0.18
EPS Estimate Current Year
4.7
EPS Estimate Next Year
5.12
EPS Estimate Current Quarter
1.1
EPS Estimate Next Quarter
1.15

Analyst Recommendation

Buy
    80%Buy
    20%Hold
    0
    0%Sell
Based on 10 Wall street analysts offering stock ratings for Ensign Group Inc(by analysts ranked 0 to 5 stars)
Based on 10 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
8
9
9
Hold
2
2
2
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 25.75%

Current $88.47
Target $111.25

Company Financials

FY17Y/Y Change
Revenue
1.8B
↑ 11.75%
Net Income
40.5M
↓ 19.03%
Net Profit Margin
2.19%
↓ 0.83%
FY18Y/Y Change
Revenue
2.0B
↑ 10.35%
Net Income
92.4M
↑ 128.2%
Net Profit Margin
4.53%
↑ 2.34%
FY19Y/Y Change
Revenue
2.0B
↓ 0.2%
Net Income
110.5M
↑ 19.67%
Net Profit Margin
5.43%
↑ 0.9%
FY20Y/Y Change
Revenue
2.4B
↑ 17.98%
Net Income
170.5M
↑ 54.23%
Net Profit Margin
7.1%
↑ 1.67%
FY21Y/Y Change
Revenue
2.6B
↑ 9.36%
Net Income
194.7M
↑ 14.18%
Net Profit Margin
7.41%
↑ 0.31%
FY22Y/Y Change
Revenue
3.0B
↑ 15.15%
Net Income
224.7M
↑ 15.43%
Net Profit Margin
7.43%
↑ 0.02%
Q4 FY21Q/Q Change
Revenue
693.1M
↑ 3.68%
Net Income
48.7M
↑ 3.09%
Net Profit Margin
7.03%
↓ 0.04%
Q1 FY22Q/Q Change
Revenue
713.4M
↑ 2.93%
Net Income
50.3M
↑ 3.28%
Net Profit Margin
7.06%
↑ 0.03%
Q2 FY22Q/Q Change
Revenue
732.5M
↑ 2.67%
Net Income
57.7M
↑ 14.6%
Net Profit Margin
7.88%
↑ 0.82%
Q3 FY22Q/Q Change
Revenue
770.0M
↑ 5.12%
Net Income
56.2M
↓ 2.62%
Net Profit Margin
7.3%
↓ 0.58%
Q4 FY22Q/Q Change
Revenue
809.5M
↑ 5.13%
Net Income
60.5M
↑ 7.64%
Net Profit Margin
7.47%
↑ 0.17%
Q1 FY23Q/Q Change
Revenue
886.8M
↑ 9.55%
Net Income
59.9M
↓ 1.02%
Net Profit Margin
6.75%
↓ 0.72%
FY17Y/Y Change
Total Assets
1.1B
↑ 10.13%
Total Liabilities
602.4M
↑ 11.44%
FY18Y/Y Change
Total Assets
1.2B
↑ 7.21%
Total Liabilities
579.6M
↓ 3.78%
FY19Y/Y Change
Total Assets
2.4B
↑ 99.83%
Total Liabilities
1.7B
↑ 194.29%
FY20Y/Y Change
Total Assets
2.5B
↑ 7.78%
Total Liabilities
1.7B
↑ 1.27%
FY21Y/Y Change
Total Assets
2.9B
↑ 11.98%
Total Liabilities
1.8B
↑ 5.88%
FY22Y/Y Change
Total Assets
3.5B
↑ 21.1%
Total Liabilities
2.2B
↑ 20.47%
Q4 FY21Q/Q Change
Total Assets
2.9B
↑ 1.32%
Total Liabilities
1.8B
↓ 0.28%
Q1 FY22Q/Q Change
Total Assets
3.0B
↑ 6.8%
Total Liabilities
2.0B
↑ 7.85%
Q2 FY22Q/Q Change
Total Assets
3.1B
↑ 2.63%
Total Liabilities
2.0B
↑ 1.59%
Q3 FY22Q/Q Change
Total Assets
3.3B
↑ 4.5%
Total Liabilities
2.1B
↑ 3.97%
Q4 FY22Q/Q Change
Total Assets
3.5B
↑ 5.72%
Total Liabilities
2.2B
↑ 5.74%
Q1 FY23Q/Q Change
Total Assets
3.9B
↑ 11.88%
Total Liabilities
2.5B
↑ 15.4%
FY17Y/Y Change
Operating Cash Flow
73.0M
↓ 1.27%
Investing Cash Flow
-106.6M
↓ 49.39%
Financing Cash Flow
18.3M
↓ 88.05%
FY18Y/Y Change
Operating Cash Flow
210.3M
↑ 188.27%
Investing Cash Flow
-151.2M
↑ 41.86%
Financing Cash Flow
-70.3M
↓ 484.99%
FY19Y/Y Change
Operating Cash Flow
192.2M
↓ 8.6%
Investing Cash Flow
-247.0M
↑ 63.36%
Financing Cash Flow
82.9M
↓ 217.83%
FY20Y/Y Change
Operating Cash Flow
373.4M
↑ 94.23%
Investing Cash Flow
-58.7M
↓ 76.25%
Financing Cash Flow
-137.3M
↓ 265.65%
FY21Y/Y Change
Operating Cash Flow
275.7M
↓ 26.16%
Investing Cash Flow
-173.9M
↑ 196.44%
Financing Cash Flow
-76.1M
↓ 44.55%
FY22Y/Y Change
Operating Cash Flow
272.5M
↓ 1.15%
Investing Cash Flow
-186.2M
↑ 7.06%
Financing Cash Flow
-32.3M
↓ 57.63%
Q4 FY21Q/Q Change
Operating Cash Flow
71.2M
↓ 25.91%
Investing Cash Flow
-116.0M
↑ 582.3%
Financing Cash Flow
2.4M
↓ 91.06%
Q1 FY22Q/Q Change
Operating Cash Flow
45.9M
↓ 35.57%
Investing Cash Flow
-48.2M
↓ 58.43%
Financing Cash Flow
-11.3M
↓ 565.72%
Q2 FY22Q/Q Change
Operating Cash Flow
83.9M
↑ 82.98%
Investing Cash Flow
-28.4M
↓ 41.22%
Financing Cash Flow
-18.5M
↑ 64.31%
Q3 FY22Q/Q Change
Operating Cash Flow
92.5M
↑ 10.23%
Investing Cash Flow
-67.2M
↑ 136.9%
Financing Cash Flow
-2.1M
↓ 88.87%
Q4 FY22Q/Q Change
Operating Cash Flow
50.2M
↓ 45.77%
Investing Cash Flow
-42.4M
↓ 36.86%
Financing Cash Flow
-359.0K
↓ 82.62%
Q1 FY23Q/Q Change
Operating Cash Flow
48.3M
↓ 3.65%
Investing Cash Flow
-36.0M
↓ 15.18%
Financing Cash Flow
-1.7M
↑ 366.3%

Technicals Summary

Sell

Neutral

Buy

Ensign Group Inc is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Ensign Group Inc
Ensign Group Inc
-8.88%
-6.08%
13.4%
105.54%
157.9%
agilon health, Inc.
agilon health, Inc.
-18.19%
10.08%
9.35%
-35.87%
-35.87%
HCA Holdings, Inc.
HCA Holdings, Inc.
-6.98%
10.79%
27.66%
142.75%
153.25%
Universal Health Services Inc.
Universal Health Services Inc.
-10.84%
1.48%
9.42%
26.33%
15.75%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Ensign Group Inc
Ensign Group Inc
21.42
21.42
1.31
4.7
0.2
0.05
0.0
23.79
agilon health, Inc.
agilon health, Inc.
NA
NA
NA
-0.11
-0.08
-0.04
0.0
2.61
HCA Holdings, Inc.
HCA Holdings, Inc.
13.31
13.31
1.37
18.16
0.21
0.11
0.01
-9.04
Universal Health Services Inc.
Universal Health Services Inc.
13.63
13.63
1.87
10.18
0.11
0.05
0.01
85.67
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Ensign Group Inc
Ensign Group Inc
Buy
$4.9B
157.9%
21.42
7.32%
agilon health, Inc.
agilon health, Inc.
Buy
$8.4B
-35.87%
NA
-2.88%
HCA Holdings, Inc.
HCA Holdings, Inc.
Buy
$72.7B
153.25%
13.31
9.42%
Universal Health Services Inc.
Universal Health Services Inc.
Hold
$9.0B
15.75%
13.63
5.05%

Institutional Holdings

  • BlackRock Inc

    17.26%
  • Vanguard Group Inc

    11.50%
  • Wasatch Advisors Inc.

    9.46%
  • Fuller & Thaler Asset Management Inc

    4.68%
  • State Street Corporation

    3.38%
  • Riverbridge Partners LLC

    2.93%

Corporate Announcements

  • Ensign Group Inc Dividends March,2023

    In the quarter ending March,2023. Ensign Group Inc has declared dividend of $0.06

    Read More

Company Information

The Ensign Group independent operating subsidiaries provide a broad spectrum of skilled nursing and assisted living services, physical, occupational and speech therapies and other rehabilitative and healthcare services at 231 healthcare facilities, in Arizona, California, Colorado, Idaho, Iowa, Kansas, Nebraska, Nevada, South Carolina, Texas, Utah, Washington and Wisconsin.

Organization
Ensign Group Inc
Employees
29900
CEO
Mr. Barry R. Port
Industry
Health Services

FAQs